| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | compound 1B | CTRPv2 | pan-cancer | AAC | -0.051 | 0.2 |
| mRNA | ISOX | CTRPv2 | pan-cancer | AAC | 0.043 | 0.2 |
| mRNA | CCT018159 | GDSC1000 | pan-cancer | AAC | -0.043 | 0.2 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | 0.042 | 0.2 |
| mRNA | CP466722 | GDSC1000 | pan-cancer | AAC | 0.037 | 0.2 |
| mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | 0.17 | 0.2 |
| mRNA | linifanib | GDSC1000 | pan-cancer | AAC | 0.043 | 0.2 |
| mRNA | BRD-K96970199 | CTRPv2 | pan-cancer | AAC | 0.092 | 0.2 |
| mRNA | BRD-K44224150 | CTRPv2 | pan-cancer | AAC | -0.094 | 0.2 |
| mRNA | BRD-K33199242 | CTRPv2 | pan-cancer | AAC | 0.049 | 0.2 |